244 related articles for article (PubMed ID: 24434154)
21. Association between promoter methylation and expression of thyroid hormone receptor beta (THRβ) gene in patients with gastric cancer in an Iranian population.
Kordi Tamandani DM; Hemati S; Davani SK; Arbabi F
J Gastroenterol Hepatol; 2015 Mar; 30(3):485-9. PubMed ID: 25302749
[TBL] [Abstract][Full Text] [Related]
22. Cystatin M expression is reduced in gastric carcinoma and is associated with promoter hypermethylation.
Chen X; Cao X; Dong W; Xia M; Luo S; Fan Q; Xie J
Biochem Biophys Res Commun; 2010 Jan; 391(1):1070-4. PubMed ID: 20004178
[TBL] [Abstract][Full Text] [Related]
23. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
[TBL] [Abstract][Full Text] [Related]
24. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
Zhao L; Cui Q; Lu Z; Chen J
Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
[TBL] [Abstract][Full Text] [Related]
25. Abnormal hypermethylation of promoter region downregulates chemokine CXC ligand 14 expression in gastric cancer.
Hu C; Lin F; Zhu G; Xue X; Ding Y; Zhao Z; Zhang L; Shen X
Int J Oncol; 2013 Nov; 43(5):1487-94. PubMed ID: 23982764
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH; Park SY; Kang GH
Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
[TBL] [Abstract][Full Text] [Related]
27. Aberrant promoter methylation of EDNRB in lung cancer in Taiwan.
Chen SC; Lin CY; Chen YH; Fang HY; Cheng CY; Chang CW; Chen RA; Tai HL; Lee CH; Chou MC; Lin TS; Hsu LS
Oncol Rep; 2006 Jan; 15(1):167-72. PubMed ID: 16328051
[TBL] [Abstract][Full Text] [Related]
28. Hypermethylation of HLA class I gene is associated with HLA class I down-regulation in human gastric cancer.
Ye Q; Shen Y; Wang X; Yang J; Miao F; Shen C; Zhang J
Tissue Antigens; 2010 Jan; 75(1):30-9. PubMed ID: 19883394
[TBL] [Abstract][Full Text] [Related]
29. Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma.
Guo X; Liu W; Pan Y; Ni P; Ji J; Guo L; Zhang J; Wu J; Jiang J; Chen X; Cai Q; Li J; Zhang J; Gu Q; Liu B; Zhu Z; Yu Y
Oncogene; 2010 Jul; 29(27):3908-20. PubMed ID: 20440264
[TBL] [Abstract][Full Text] [Related]
30. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation.
Dong SW; Cui YT; Zhong RR; Liang DC; Liu YM; Wang YG; He Z; Wang S; Liang SJ; Zhang P
Clin Lab; 2012; 58(1-2):41-51. PubMed ID: 22372344
[TBL] [Abstract][Full Text] [Related]
31. Co-expression of laminin β3 and γ2 chains and epigenetic inactivation of laminin α3 chain in gastric cancer.
Ii M; Yamamoto H; Taniguchi H; Adachi Y; Nakazawa M; Ohashi H; Tanuma T; Sukawa Y; Suzuki H; Sasaki S; Imai K; Shinomura Y
Int J Oncol; 2011 Sep; 39(3):593-9. PubMed ID: 21617852
[TBL] [Abstract][Full Text] [Related]
32. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
33. Frequent silencing of popeye domain-containing genes, BVES and POPDC3, is associated with promoter hypermethylation in gastric cancer.
Kim M; Jang HR; Haam K; Kang TW; Kim JH; Kim SY; Noh SM; Song KS; Cho JS; Jeong HY; Kim JC; Yoo HS; Kim YS
Carcinogenesis; 2010 Sep; 31(9):1685-93. PubMed ID: 20627872
[TBL] [Abstract][Full Text] [Related]
34. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.
Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM
Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer.
Chang HC; Cho CY; Hung WC
Cancer Sci; 2007 Feb; 98(2):169-73. PubMed ID: 17233834
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of CXCL12 by DNA hypermethylation and its involvement in gastric cancer metastatic progression.
Zhi Y; Chen J; Zhang S; Chang X; Ma J; Dai D
Dig Dis Sci; 2012 Mar; 57(3):650-9. PubMed ID: 21960286
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X
Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964
[TBL] [Abstract][Full Text] [Related]
38. Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation.
Cao YM; Gu J; Zhang YS; Wei WJ; Qu N; Wen D; Liao T; Shi RL; Zhang L; Ji QH; Wang Y; Sun GH; Zhao YX; Wang YJ; Yu J; Zhu YX
Oncol Rep; 2018 Jan; 39(1):338-348. PubMed ID: 29115628
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
[TBL] [Abstract][Full Text] [Related]
40. [Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer].
Liu WT; Jiao HL; Yang YL; Wang D; Zhang WM
Ai Zheng; 2007 Nov; 26(11):1199-203. PubMed ID: 17991318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]